This page shows the latest Rixathon/Riximyo news and features for those working in and with pharma, biotech and healthcare.
Sandoz will sell its biosimilar under the Rixathon/Riximyo brand names, and the firm's biopharma head, Carol Lynch, said the approval is "a big win for patients in Europe with ... There is no word on pricing for Rixathon just yet, but biosimilars
More from news
Approximately 1 fully matching, plus 0 partially matching documents found.
3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...